Moderna's Flu Vaccine Receives Unanimous FDA Panel Endorsement

Moderna's flu vaccine has received a unanimous endorsement from an FDA advisory panel, moving it closer to potential approval.

18 Jun, 12:45 — 18 Jun, 12:45

Post Share

Sources

Showing 1 of 2 sources

The GuardianMostly Factual52d ago

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic. Moderna is seeking Food and Drug Administration (FDA) approval of its new shot , dubbed mFlusiva, as an option for people 50 and older. The FDA advisory committee meeting is a step toward a final decision ahead of the winter flu season. Continue reading...

By Associated Press

Read full article →

Coverage Timeline

First report: The Guardian · 18 Jun, 12:45|Full coverage: 2 · 8h|Window: 8h

Left-leaningCenterRight-leaning

The Guardian18 Jun, 12:45First to report

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

8h later

seeking-alpha18 Jun, 21:00Latest update

PERSPECTA

PERSPECTA

Moderna's Flu Vaccine Receives Unanimous FDA Panel Endorsement

Sources

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

Coverage Timeline

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

Moderna gains unanimous FDA panel endorsement of flu vaccine

Related Stories

MTN Nigeria Confirms 25GB Data Reward, Warns Against Fake Links

Erdinger Owner Werner Brombach Dies

West Bengal to Audit Industrial Parks, Submit BHAVYA Proposals

Climate Change Threatens Nigerian Coastal Fishermen's Livelihoods

PERSPECTA